ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269599; 2) Community: the network communities that were significantly associated with the response to NSC 269599; 3) Molecule: the relationships between components within communities and NSC 269599; 4) MDR: the compounds that were significantly associated with the NSC 269599.

NSC Compound Enrichment Correlation
NSC 708559 Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) 0.0414190425892871 0.26285886
NSC 714379 Null 0.0414190425892871 0.27197171
NSC 721049 7Z-Plakortide H 0.0414190425892871 0.13669591
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0414190425892871 0.31129034
NSC 737231 Null 0.0414190425892871 0.30809871
NSC 740476 Null 0.0414190425892871 0.17405699
NSC 746053 Null 0.0414190425892871 0.24774533
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0414190425892871 0.5891658
NSC 758881 Orlistat (USAN) 0.0414190425892871 0.15978506
NSC 759178 Pipamperone 0.0414190425892871 0.43587653
Total:115  Current:101    [First] [Prev] [Next] [Last]